Share the Video:

Preview Scene from Prescription X: The Rick Doblin and MAPS Documentary (Work in Progress)

Nirvan Mullick, Dream Mullick

Filmed for over nine years (with unprecedented access), Prescription X: The Rick Doblin Story follows the colorful life of Dr. Rick Doblin and the team at MAPS on a multi-decade journey to legalize MDMA and psychedelics for therapeutic use, pioneering psychedelic research along the way. The film will be released after MDMA is rescheduled and will tell the true story of how this unlikely team achieved what many thought to be impossible. With brother/sister Nirvan Mullick (Director) and Dream Mullick (Producer). PrescriptionX.com

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

TREAT CALIFORNIA-Providing $5 Billion to Fund Psychedelic Research and Therapies

TREAT California initiative aims to transform mental healthcare in California with $5 Billion funding for psychedelic medicine research and access, inspired by successful stem cell agency model.

Jeannie Moller Fontana

PS2023 Healing for All Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research

An Overview of Current State Frameworks for Psychedelic Healing

Leaders of Oregon and Colorado campaigns discuss the historic creation of state frameworks for psychedelic healing, detailing the journey, current status, and future directions. Total words: 26

Kevin Matthews, Joshua Kappel

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research Research and Science

What Will People Think? Revealing Public Knowledge, Belief, and Perceptions of Psychedelics

Imran Khan presents findings of the Psychedelic Insight Poll, a national survey by the Berkeley Center for the Science of Psychedelics to understand public perceptions of psychedelic substances. The poll

Imran Khan

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research Social Justice

Safety and accountability in psychedelic communities

Dr. Smith and Dr. Jones explore advancements in psychedelic research and therapy, highlighting key findings and implications for mental health treatment.

Hannah McLane, Brad Adams

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research Social and Cultural

Psychedelic education today: kids, parents, and the public

Panel discusses equipping parents with youth drug use info, fostering open conversations, and addressing public perception. Transformative drug education empowers communities, dismantles stigma, and cultivates informed society.

Vilmarie Narloch, Rhana Hashemi, Stefanie Jones, Gina Giorgio

PS2023 MDMA Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research Research and Science

Priorities for the next generation of psychedelic science

NIMH Director Joshua A. Gordon and trauma researcher Barbara O. Rothbaum discuss the current state and future directions of psychedelic research, emphasizing the need for deeper understanding and robust study

Joshua A Gordon

PS2023 Harm Reduction Integration Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research

Responding to Crises and Calls with Psychedelic Harm Reduction

Panelists from Zendo Project, Fireside Project, Kosmicare, and Anashim Tovim discuss harm reduction strategies in the psychedelic ecosystem, emphasizing innovation, compassion, and scientific expertise in diverse settings. They provide case

Joshua White, Daniel E Martin, Pinni Baumol, Shirelle Noble, Ben Halper

PS2023 Policy Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Building momentum for new state policy approaches

Expansion of psychedelic policy in the US includes decriminalization, adult use regulations, and increased research funding. Elected state lawmakers discuss challenges, opportunities, and lessons from proposed psychedelic legislation.

Rep La Shawn Ford (IL), Rep Alex Dominguez (TX), Tamar Todd

PS2023 Harm Reduction Policy and Advocacy Psychedelic Science Public Benefit Research Social Justice

Proactive harm reduction by preparing set, setting, and substance

Harm reduction superheroes delve into risk mitigation and benefit maximization, exploring mindset, setting, and substances for safer drug experiences and systemic change.

Mitchell Gomez, Phoenix aka Mohawk Greene

Preview Scene from Prescription X: The Rick Doblin and MAPS Documentary (Work in Progress)

Become a MAPS Member with a monthly donation

Related Videos